The Vanguard Group 13D and 13G filings for Denali Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:02 pm Purchase |
2023-12-29 | 13G | Denali Therapeutics Inc. DNLI |
The Vanguard Group | 10,834,483 7.840% |
887,385 (+8.92%) |
Filing |
| 2023-02-09 11:16 am Purchase |
2022-12-30 | 13G | Denali Therapeutics Inc. DNLI |
The Vanguard Group | 9,947,098 7.320% |
1,785,568 (+21.88%) |
Filing |
| 2022-02-09 3:43 pm Purchase |
2021-12-31 | 13G | Denali Therapeutics Inc. DNLI |
The Vanguard Group | 8,161,530 6.680% |
236,473 (+2.98%) |
Filing |
| 2021-02-10 10:46 am Purchase |
2020-12-31 | 13G | Denali Therapeutics Inc. DNLI |
The Vanguard Group | 7,925,057 6.610% |
1,717,515 (+27.67%) |
Filing |